181 related articles for article (PubMed ID: 31727359)
41. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.
Hoehle SI; Pfeiffer E; Metzler M
Mol Nutr Food Res; 2007 Aug; 51(8):932-8. PubMed ID: 17628876
[TBL] [Abstract][Full Text] [Related]
42. Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.
Sridar C; Goosen TC; Kent UM; Williams JA; Hollenberg PF
Drug Metab Dispos; 2004 Jun; 32(6):587-94. PubMed ID: 15155549
[TBL] [Abstract][Full Text] [Related]
43. Silybin and its congeners: from traditional medicine to molecular effects.
Křen V; Valentová K
Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639
[TBL] [Abstract][Full Text] [Related]
44. N-glucuronidation of perfluorooctanesulfonamide by human, rat, dog, and monkey liver microsomes and by expressed rat and human UDP-glucuronosyltransferases.
Xu L; Krenitsky DM; Seacat AM; Butenhoff JL; Tephly TR; Anders MW
Drug Metab Dispos; 2006 Aug; 34(8):1406-10. PubMed ID: 16720684
[TBL] [Abstract][Full Text] [Related]
45. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
46. Influence of exogenous salicylic acid on flavonolignans and lipoxygenase activity in the hairy root cultures of Silybum marianum.
Khalili M; Hasanloo T; Kazemi Tabar SK; Rahnama H
Cell Biol Int; 2009 Sep; 33(9):988-94. PubMed ID: 19524695
[TBL] [Abstract][Full Text] [Related]
47. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
Bijak M
Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
[TBL] [Abstract][Full Text] [Related]
48. The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan.
Alonen A; Finel M; Kostiainen R
Biochem Pharmacol; 2008 Sep; 76(6):763-72. PubMed ID: 18674515
[TBL] [Abstract][Full Text] [Related]
49. Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases.
Lv X; Zhang JB; Wang XX; Hu WZ; Shi YS; Liu SW; Hao DC; Zhang WD; Ge GB; Hou J; Yang L
Chem Biol Interact; 2018 Mar; 284():48-55. PubMed ID: 29470958
[TBL] [Abstract][Full Text] [Related]
50. Industrial Approach to Determine the Relative Contribution of Seven Major UGT Isoforms to Hepatic Glucuronidation.
Busse D; Leandersson S; Amberntsson S; Darnell M; Hilgendorf C
J Pharm Sci; 2020 Jul; 109(7):2309-2320. PubMed ID: 32294459
[TBL] [Abstract][Full Text] [Related]
51. Farnesol is glucuronidated in human liver, kidney and intestine in vitro, and is a novel substrate for UGT2B7 and UGT1A1.
Staines AG; Sindelar P; Coughtrie MW; Burchell B
Biochem J; 2004 Dec; 384(Pt 3):637-45. PubMed ID: 15320866
[TBL] [Abstract][Full Text] [Related]
52. UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation.
Nishiyama T; Ohnuma T; Inoue Y; Kishi T; Ogura K; Hiratsuka A
Biochem Biophys Res Commun; 2008 Jun; 371(2):247-50. PubMed ID: 18423374
[TBL] [Abstract][Full Text] [Related]
53. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
[TBL] [Abstract][Full Text] [Related]
54. Tyrosinase inhibitory study of flavonolignans from the seeds of Silybum marianum (Milk thistle).
Kim JY; Kim JY; Jenis J; Li ZP; Ban YJ; Baiseitova A; Park KH
Bioorg Med Chem; 2019 Jun; 27(12):2499-2507. PubMed ID: 30871862
[TBL] [Abstract][Full Text] [Related]
55. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases.
Yan Z; Caldwell GW; Gauthier D; Leo GC; Mei J; Ho CY; Jones WJ; Masucci JA; Tuman RW; Galemmo RA; Johnson DL
Drug Metab Dispos; 2006 May; 34(5):748-55. PubMed ID: 16455802
[TBL] [Abstract][Full Text] [Related]
56. Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids.
Mazur A; Lichti CF; Prather PL; Zielinska AK; Bratton SM; Gallus-Zawada A; Finel M; Miller GP; Radomińska-Pandya A; Moran JH
Drug Metab Dispos; 2009 Jul; 37(7):1496-504. PubMed ID: 19339377
[TBL] [Abstract][Full Text] [Related]
57. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
Malfatti MA; Felton JS
Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
[TBL] [Abstract][Full Text] [Related]
58. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
59. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
[TBL] [Abstract][Full Text] [Related]
60. Variation in the flavonolignan composition of fruits from different Silybum marianum chemotypes and suspension cultures derived therefrom.
Poppe L; Petersen M
Phytochemistry; 2016 Nov; 131():68-75. PubMed ID: 27639292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
